Mexico has so far acquired 16.9 million vaccine doses for its population of 126 million, all from foreign companies including Pfizer-BioNTech, Sinovac, AstraZeneca, CanSino and Sputnik V, according to government data.
The costs to acquire Avimex’s vaccine would be 800% lower than imported foreign vaccines, the government said.
The government says the real case numbers are likely to be significantly higher, and separate health ministry data suggests the actual death toll may be at least 60% above the confirmed figure.
Avimex’s version, however, is the only one to be tested using an active virus, a company spokeswoman said. The Avimex version is also the only one being tested as an intranasal spray as well as an injection, she said."